On-demand intracellular amplification of chemoradiation with cancer-specific plasmonic nanobubbles

Nature Medicine

Volumn 20, Issue 7, 2014, Pages 778-784

  Lukianova Hleb, Ekaterina Y ^a   Ren, Xiaoyang ^b   Sawant, Rupa R ^c   Wu, Xiangwei ^b   Torchilin, Vladimir P ^c   Lapotko, Dmitri O ^a  

^a RICE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; DOXORUBICIN; GOLD NANOPARTICLE; LIPOSOME; NANOBUBBLE; PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL DESTRUCTION; CANCER CHEMOTHERAPY; CELL EXPANSION; CHEMORADIOTHERAPY; CONTROLLED STUDY; CYTOPLASM; DRUG EFFICACY; DRUG POTENTIATION; ENDOSOME; HEAD AND NECK CANCER; IN VITRO STUDY; IN VIVO STUDY; LOW LEVEL LASER THERAPY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT RESPONSE; TUMOR RECURRENCE; X RAY;

ANIMALS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; HEAD AND NECK NEOPLASMS; HUMANS; MICE; NANOSTRUCTURES; TREATMENT OUTCOME;

EID: 84904048671     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3484     Document Type: Article

References (58)

1. Meier, J.D., Oliver, D.A. & Varvares, M.A. Surgical margin determination in head and neck oncology: current clinical practice. The results of an International American Head and Neck Society Member Survey. Head Neck 27, 952-958 (2005).
2. Langendijk, J.A. et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J. Clin. Oncol. 26, 3770-3776 (2008).
3. Libutti, S.K. et al. Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin. Cancer Res. 16, 6139-6149 (2010).
4. Kean, W.F. & Kean, I.R. Clinical pharmacology of gold. Inflammopharmacology 16, 112-125 (2008).
5. Sharafinski, M.E., Ferris, R.L., Ferrone, S. & Grandis, J.R. Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32, 1412-1421 (2010).
6. Iakoubov, L., Rokhlin, O. & Torchilin, V. Anti-nuclear autoantibodies of the aged reactive against the surface of tumor but not normal cells. Immunol. Lett. 47, 147-149 (1995).
7. Lukianova-Hleb, E. et al. Plasmonic nanobubbles as transient vapor nanobubbles generated around plasmonic nanoparticles. ACS Nano 4, 2109-2123 (2010).
8. Lukianova-Hleb, E.Y. et al. Improved cellular specificity of plasmonic nanobubbles versus nanoparticles in heterogeneous cell systems. PLo S ONE 7, e34537 (2012).
9. Lukianova-Hleb, E.Y., Ren, X., Zasadzinski, J.A., Wu, X. & Lapotko, D. Plasmonic nanobubbles enhance efficacy and selectivity of chemotherapy against drug-resistant cancer cells. Adv. Mater. 24, 3831-3837 (2012).
10. Koukourakis, M.I. et al. Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer. J. Clin. Oncol. 17, 3512-3521 (1999).
11. Torchilin, V.P., Lukyanov, A.N., Gao, Z. & Papahadjopoulos-Sternberg, B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. USA 100, 6039-6044 (2003).
12. Wagner, D.S. et al. The in vivo performance of plasmonic nanobubbles as cell theranostic agents in zebrafish hosting prostate cancer xenografts. Biomaterials 31, 7567-7574 (2010).
13. Hainfeld, J.F. et al. Gold nanoparticles enhance the radiation therapy of a murine squamous cell carcinoma. Phys. Med. Biol. 55, 3045-3059 (2010).
14. Hainfeld, J.F., Slatkin, D.N. & Smilowitz, H.M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, N309-N315 (2004).
15. Calais, G. et al. Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy. Bull. Cancer 87, 48-53 (2000).
16. Sano, D. et al. Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro. Clin. Cancer Res. 17, 1815-1827 (2011).
17. Sano, D. et al. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Clin. Cancer Res. 17, 6658-6670 (2011).
18. Lukianova-Hleb, E.Y., Volkov, A.N., Wu, X. & Lapotko, D.O. Transient enhancement and spectral narrowing of the photothermal effect of plasmonic nanoparticles under pulsed excitation. Adv. Mater. 25, 772-776 (2013).
19. Welch, A.J. & van Gemert, M.J.C. in Optical-Thermal Response of Laser-Irradiated Tissue 2nd edn. (eds. Welch, A.J. & van Gemert, M.J.C.) 3-11 (Springer, 2011).
20. Ambrosch, P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr. Opin. Otolaryngol. Head Neck Surg. 15, 82-88 (2007).
21. Karni, R.J., Rich, J.T., Sinha, P. & Haughey, B.H. Transoral laser microsurgery: a new approach for unknown primaries of the head and neck. Laryngoscope 121, 1194-1201 (2011).
22. Lukianova-Hleb, E.Y. & Lapotko, D. Influence of transient environmental photothermal effects on optical scattering by gold nanoparticles. Nano Lett. 9, 2160-2166 (2009).
23. Rahman, W.N. et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 5, 136-142 (2009).
24. Jiao, P. et al. Leading neuroblastoma cells to die by multiple premeditated attacks from a multifunctionalized nanoconstruct. J. Am. Chem. Soc. 133, 13918-13921 (2011).
25. Argiris, A., Karamouzis, M.V., Raben, D. & Ferris, R.L. Head and neck cancer. Lancet 371, 1695-1709 (2008).
26. Jegannathen, A. et al. Synchronous chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck using capecitabine: a single-centre, open-label, single-group phase II study. Clin. Oncol. (R Coll Radiol) 23, 149-158 (2011).
27. Chen, Y. et al. Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy a therapeutic approach on the basis of preclinical research of human cancer cell lines. Clin. Cancer Res. 9, 969-975 (2003).
28. Paliwal, S. & Mitragotri, S. Ultrasound-induced cavitation: applications in drug and gene delivery. Expert Opin. Drug Deliv. 3, 713-726 (2006).
29. Czarnota, G.J. et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature. Proc. Natl. Acad. Sci. USA 109, E2033-E2041 (2012).
30. Rapoport, N. et al. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions. J. Control. Release 153, 4-15 (2011).
31. Gao, Z., Kennedy, A.M., Christensen, D.A. & Rapoport, N.Y. Drug-loaded nano/microbubbles for combining ultrasonography and targeted chemotherapy. Ultrasonics 48, 260-270 (2008).
32. Rapoport, N. Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery. Prog. Polym. Sci. 32, 962-990 (2007).
33. Rapoport, N.Y., Gao, Z., Kamaev, P. & Christensen, D.A. Ultrasound-enhanced localized chemotherapy of drug-sensitive and multidrug resistant tumors. AIP Conf. Proc. 829, 481 (2006).
34. Allen, T.M. & Cullis, P.R. Drug delivery systems: entering the mainstream. Science 303, 1818-1822 (2004).
35. Schroeder, A. et al. Treating metastatic cancer with nanotechnology. Nat. Rev. Cancer 12, 39-50 (2011).
36. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2, 751-760 (2007).
37. de Carvalho, A.C. et al. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients. Oral Oncol. 48, 240-248 (2012).
38. Zhang, H.F., Maslov, K., Stoica, G. & Wang, L.V. Functional photoacoustic microscopy for high-resolution and noninvasive in vivo imaging. Nat. Biotechnol. 24, 848-851 (2006).
39. Qian, X. et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26, 83-90 (2008).
40. Merchant, B. Gold, the noble metal and the paradoxes of its toxicology. Biologicals 26, 49-59 (1998).
41. Root, S.W., Andrews, G.A., Kniseley, R.M. & Tyor, M.P. The distribution and radiation effects of intravenously administered colloidal gold-198 in man. Cancer 7, 856-866 (1954).
42. Lapotko, D.O., Lukianova-Hleb, E. & Oraevsky, A. Clusterization of nanoparticles during their interaction with living cells. Nanomedicine 2, 241-253 (2007).
43. Weissleder, R. A clearer vision for in vivo imaging. Nat. Biotechnol. 19, 316-317 (2001).
44. Qian, X. et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat. Biotechnol. 26, 83-90 (2008).
45. Vogl, T.J., Naguib, N.N., Lehnert, T. & Nour-Eldin, N.E. Radiofrequency, microwave and laser ablation of pulmonary neoplasms: clinical studies and technical considerations-review article. Eur. J. Radiol. 77, 346-357 (2011).
46. O'Neal, D.P., Hirsch, L.R., Halas, N.J., Payne, J.D. & West, J.L. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209, 171-176 (2004).
47. Roedel, R.M. et al. Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer. Auris Nasus Larynx 37, 474-481 (2010).
48. Agarwal, A., Mac Key, M.A., El-Sayed, M.A. & Bellamkonda, R.V. Remote triggered release of doxorubicin in tumors by synergistic application of thermosensitive liposomes and gold nanorods. ACS Nano 5, 4919-4926 (2011).
49. Braun, G.B. et al. Laser-activated gene silencing via gold nanoshell-siRNA conjugates. ACS Nano 3, 2007-2015 (2009).
50. Park, J.H. et al. Cooperative nanoparticles for tumor detection and photothermally triggered drug delivery. Adv. Mater. 22, 880-885 (2010).
51. O'Neill, B.E. & Rapoport, N. Phase-shift, stimuli-responsive drug carriers for targeted drug delivery. Ther. Deliv. 2, 1165-1187 (2011).
52. Rapoport, N., Gao, Z. & Kennedy, A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J. Natl. Cancer Inst. 99, 1095-1106 (2007).
53. Panyam, J. & Labhasetwar, V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55, 329-347 (2003).
54. Kamaly, N. et al. Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem. Soc. Rev. 41, 2971-3010 (2012).
55. Qiu, Y. & Park, K. Environment-sensitive hydrogels for drug delivery. Adv. Drug Deliv. Rev. 53, 321-339 (2001).
56. Ferrara, K.W. Driving delivery vehicles with ultrasound. Adv. Drug Deliv. Rev. 60, 1097-1102 (2008).
57. Rapoport, N.Y., Kennedy, A.M., Shea, J.E., Scaife, C.L. & Nam, K.H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Control. Release 138, 268-276 (2009).
58. Kennedy, J.E. High-intensity focused ultrasound in the treatment of solid tumours. Nat. Rev. Cancer 5, 321-327 (2005).